Cleveland Clinic Lerner of College of Medicine, Cleveland, OH, USA.
Department of General Surgery, Bariatric and Metabolic Institute, Cleveland Clinic, Mail Code M61, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
Surg Endosc. 2019 May;33(5):1654-1660. doi: 10.1007/s00464-018-6458-8. Epub 2018 Sep 24.
Bariatric surgery has been shown to improve and resolve diabetes. However, limited literature about its impact on end-organ complications of diabetes is available. The aim of this study was to examine the long-term effect of bariatric surgery on albuminuria.
We studied 101 patients with pre-operative diabetes and albuminuria [defined as urine albumin:creatinine ratio (uACR) > 30 mg/g] who underwent bariatric surgery at an academic center from 2005 to 2014.
Fifty-seven patients (56%) were female with a mean age of 53 (± 11) years. The mean pre-operative BMI and glycated hemoglobin (HbA1c) were 43.1 (± 7.6) kg/m and 8.4 (± 1.8)%, respectively. The median pre-operative uACR was 80.0 (45.0-231.0) mg/g. Bariatric procedures included Roux-en-Y gastric bypass (n = 75, 74%) and sleeve gastrectomy (n = 26, 26%). The mean follow-up period was 61 (± 29) months. At last follow-up, the mean BMI was 33.8 (± 8.3) kg/m. The overall glycemic control improved after bariatric surgery. At last follow-up, 73% had good glycemic control (HbA1c < 7%) and 27% met diabetes remission criteria. The mean HbA1c at last follow-up was 6.7 (± 1.0)% and the median uACR was 30 (IQR 7-94) mg/g. Albuminuria improved in 77% and resolved in 51% of patients at long-term.
Bariatric surgery has a significantly positive impact on albuminuria in patients with obesity and type 2 diabetes. Our data showed almost an 80% improvement in albuminuria at the short- and long-term period after bariatric surgery.
减重手术已被证明可改善和解决糖尿病问题。然而,目前关于其对糖尿病终末器官并发症影响的文献有限。本研究旨在探讨减重手术对白蛋白尿的长期影响。
我们研究了 2005 年至 2014 年期间在一家学术中心接受减重手术的 101 例术前合并糖尿病和白蛋白尿[定义为尿白蛋白与肌酐比值(uACR)>30mg/g]患者。
57 例(56%)患者为女性,平均年龄为 53(±11)岁。术前平均 BMI 和糖化血红蛋白(HbA1c)分别为 43.1(±7.6)kg/m 和 8.4(±1.8)%。术前 uACR 的中位数为 80.0(45.0-231.0)mg/g。减重手术方式包括 Roux-en-Y 胃旁路术(n=75,74%)和袖状胃切除术(n=26,26%)。平均随访时间为 61(±29)个月。末次随访时,平均 BMI 为 33.8(±8.3)kg/m。减重手术后整体血糖控制得到改善。末次随访时,73%的患者血糖控制良好(HbA1c<7%),27%的患者达到糖尿病缓解标准。末次随访时的平均 HbA1c 为 6.7(±1.0)%,uACR 的中位数为 30(IQR 7-94)mg/g。白蛋白尿在 77%的患者中得到改善,51%的患者在长期随访中得到缓解。
减重手术对肥胖合并 2 型糖尿病患者的白蛋白尿有显著的积极影响。我们的数据显示,减重手术后短期和长期白蛋白尿分别改善了近 80%。